Overexpression of the Oncogene c-erbB-2 (HER2/neu) and Response to Chemotherapy in Patients with Ovarian Cancer

SummaryThis study was designed to determine whether c-erbB-2 overexpression could be used as a marker to identify a subgroup of patients with ovarian cancer more likely than others to benefit from chemotherapy. Paraffin sections from tissue blocks from 208 patients with newly diagnosed untreated ova